Well-differentiated epithelial thyroid cancer management in the Asia Pacific region: A report and clinical practice guideline

Felix Sundram, Bruce G. Robinson, Annie Kung, Mary Anne Lim-Abrahan, Nguyen Quang Bay, Loh Keh Chuan, Jae Hoon Chung, Shih Ming Huang, Li Cho Hsu, Nor Azmi Kamaruddin, Wei Keat Cheah, Won Bae Kim, Sung Soo Koong, Hong Da Lin, Ampica Mangklabruks, Elizabeth Paz-Pacheco, Abu Rauff, Paul W. Ladenson

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Context: Thyroid cancer is among the 10 most common malignancies in populations in the Asia Pacific region, where access to various relevant health care resources varies widely. Objective: An expert consensus conference was held to define regional patterns of practice and guidelines for optimal management of well-differentiated epithelial thyroid carcinomas. Results: Practice patterns vary from country to country, as would be anticipated form their variety of ethnic and racial populations, health care systems, economies, and cultures. Thyroid cancer care is provided by a number of medical and surgical specialists, usually including endocrinologists. The thyroid surgical skills, experience, and outcomes vary widely in the region. Radioiodine is available, to a greater or lesser extent, is almost all countries. Laboratory services for thyroid function monitoring are universally accessible; thyroglobulin assays are available in most countries. Recombinant thyrotropin is approved for use in only two countries, but can be accessed in some others on a "named patient" compassionate need basis. Access to advanced imaging, for example, positron emission tomography (PET) scanning, is limited to a few countries. Conclusions: In light of these realities, appropriate strategies for initial treatment and postoperative monitoring of patients with thyroid cancer have been defined, and these are presented and discussed.

Original languageEnglish
Pages (from-to)461-469
Number of pages9
JournalThyroid
Volume16
Issue number5
DOIs
Publication statusPublished - May 2006

Fingerprint

Thyroid Neoplasms
Practice Guidelines
Thyroid Gland
Delivery of Health Care
Thyroglobulin
Health Resources
Physiologic Monitoring
Thyrotropin
Positron-Emission Tomography
Population
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Endocrinology

Cite this

Sundram, F., Robinson, B. G., Kung, A., Lim-Abrahan, M. A., Bay, N. Q., Chuan, L. K., ... Ladenson, P. W. (2006). Well-differentiated epithelial thyroid cancer management in the Asia Pacific region: A report and clinical practice guideline. Thyroid, 16(5), 461-469. https://doi.org/10.1089/thy.2006.16.461

Well-differentiated epithelial thyroid cancer management in the Asia Pacific region : A report and clinical practice guideline. / Sundram, Felix; Robinson, Bruce G.; Kung, Annie; Lim-Abrahan, Mary Anne; Bay, Nguyen Quang; Chuan, Loh Keh; Chung, Jae Hoon; Huang, Shih Ming; Hsu, Li Cho; Kamaruddin, Nor Azmi; Cheah, Wei Keat; Kim, Won Bae; Koong, Sung Soo; Lin, Hong Da; Mangklabruks, Ampica; Paz-Pacheco, Elizabeth; Rauff, Abu; Ladenson, Paul W.

In: Thyroid, Vol. 16, No. 5, 05.2006, p. 461-469.

Research output: Contribution to journalArticle

Sundram, F, Robinson, BG, Kung, A, Lim-Abrahan, MA, Bay, NQ, Chuan, LK, Chung, JH, Huang, SM, Hsu, LC, Kamaruddin, NA, Cheah, WK, Kim, WB, Koong, SS, Lin, HD, Mangklabruks, A, Paz-Pacheco, E, Rauff, A & Ladenson, PW 2006, 'Well-differentiated epithelial thyroid cancer management in the Asia Pacific region: A report and clinical practice guideline', Thyroid, vol. 16, no. 5, pp. 461-469. https://doi.org/10.1089/thy.2006.16.461
Sundram, Felix ; Robinson, Bruce G. ; Kung, Annie ; Lim-Abrahan, Mary Anne ; Bay, Nguyen Quang ; Chuan, Loh Keh ; Chung, Jae Hoon ; Huang, Shih Ming ; Hsu, Li Cho ; Kamaruddin, Nor Azmi ; Cheah, Wei Keat ; Kim, Won Bae ; Koong, Sung Soo ; Lin, Hong Da ; Mangklabruks, Ampica ; Paz-Pacheco, Elizabeth ; Rauff, Abu ; Ladenson, Paul W. / Well-differentiated epithelial thyroid cancer management in the Asia Pacific region : A report and clinical practice guideline. In: Thyroid. 2006 ; Vol. 16, No. 5. pp. 461-469.
@article{834aa2551f244a90b0e771f901ebb7f8,
title = "Well-differentiated epithelial thyroid cancer management in the Asia Pacific region: A report and clinical practice guideline",
abstract = "Context: Thyroid cancer is among the 10 most common malignancies in populations in the Asia Pacific region, where access to various relevant health care resources varies widely. Objective: An expert consensus conference was held to define regional patterns of practice and guidelines for optimal management of well-differentiated epithelial thyroid carcinomas. Results: Practice patterns vary from country to country, as would be anticipated form their variety of ethnic and racial populations, health care systems, economies, and cultures. Thyroid cancer care is provided by a number of medical and surgical specialists, usually including endocrinologists. The thyroid surgical skills, experience, and outcomes vary widely in the region. Radioiodine is available, to a greater or lesser extent, is almost all countries. Laboratory services for thyroid function monitoring are universally accessible; thyroglobulin assays are available in most countries. Recombinant thyrotropin is approved for use in only two countries, but can be accessed in some others on a {"}named patient{"} compassionate need basis. Access to advanced imaging, for example, positron emission tomography (PET) scanning, is limited to a few countries. Conclusions: In light of these realities, appropriate strategies for initial treatment and postoperative monitoring of patients with thyroid cancer have been defined, and these are presented and discussed.",
author = "Felix Sundram and Robinson, {Bruce G.} and Annie Kung and Lim-Abrahan, {Mary Anne} and Bay, {Nguyen Quang} and Chuan, {Loh Keh} and Chung, {Jae Hoon} and Huang, {Shih Ming} and Hsu, {Li Cho} and Kamaruddin, {Nor Azmi} and Cheah, {Wei Keat} and Kim, {Won Bae} and Koong, {Sung Soo} and Lin, {Hong Da} and Ampica Mangklabruks and Elizabeth Paz-Pacheco and Abu Rauff and Ladenson, {Paul W.}",
year = "2006",
month = "5",
doi = "10.1089/thy.2006.16.461",
language = "English",
volume = "16",
pages = "461--469",
journal = "Thyroid",
issn = "1050-7256",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Well-differentiated epithelial thyroid cancer management in the Asia Pacific region

T2 - A report and clinical practice guideline

AU - Sundram, Felix

AU - Robinson, Bruce G.

AU - Kung, Annie

AU - Lim-Abrahan, Mary Anne

AU - Bay, Nguyen Quang

AU - Chuan, Loh Keh

AU - Chung, Jae Hoon

AU - Huang, Shih Ming

AU - Hsu, Li Cho

AU - Kamaruddin, Nor Azmi

AU - Cheah, Wei Keat

AU - Kim, Won Bae

AU - Koong, Sung Soo

AU - Lin, Hong Da

AU - Mangklabruks, Ampica

AU - Paz-Pacheco, Elizabeth

AU - Rauff, Abu

AU - Ladenson, Paul W.

PY - 2006/5

Y1 - 2006/5

N2 - Context: Thyroid cancer is among the 10 most common malignancies in populations in the Asia Pacific region, where access to various relevant health care resources varies widely. Objective: An expert consensus conference was held to define regional patterns of practice and guidelines for optimal management of well-differentiated epithelial thyroid carcinomas. Results: Practice patterns vary from country to country, as would be anticipated form their variety of ethnic and racial populations, health care systems, economies, and cultures. Thyroid cancer care is provided by a number of medical and surgical specialists, usually including endocrinologists. The thyroid surgical skills, experience, and outcomes vary widely in the region. Radioiodine is available, to a greater or lesser extent, is almost all countries. Laboratory services for thyroid function monitoring are universally accessible; thyroglobulin assays are available in most countries. Recombinant thyrotropin is approved for use in only two countries, but can be accessed in some others on a "named patient" compassionate need basis. Access to advanced imaging, for example, positron emission tomography (PET) scanning, is limited to a few countries. Conclusions: In light of these realities, appropriate strategies for initial treatment and postoperative monitoring of patients with thyroid cancer have been defined, and these are presented and discussed.

AB - Context: Thyroid cancer is among the 10 most common malignancies in populations in the Asia Pacific region, where access to various relevant health care resources varies widely. Objective: An expert consensus conference was held to define regional patterns of practice and guidelines for optimal management of well-differentiated epithelial thyroid carcinomas. Results: Practice patterns vary from country to country, as would be anticipated form their variety of ethnic and racial populations, health care systems, economies, and cultures. Thyroid cancer care is provided by a number of medical and surgical specialists, usually including endocrinologists. The thyroid surgical skills, experience, and outcomes vary widely in the region. Radioiodine is available, to a greater or lesser extent, is almost all countries. Laboratory services for thyroid function monitoring are universally accessible; thyroglobulin assays are available in most countries. Recombinant thyrotropin is approved for use in only two countries, but can be accessed in some others on a "named patient" compassionate need basis. Access to advanced imaging, for example, positron emission tomography (PET) scanning, is limited to a few countries. Conclusions: In light of these realities, appropriate strategies for initial treatment and postoperative monitoring of patients with thyroid cancer have been defined, and these are presented and discussed.

UR - http://www.scopus.com/inward/record.url?scp=33745190962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745190962&partnerID=8YFLogxK

U2 - 10.1089/thy.2006.16.461

DO - 10.1089/thy.2006.16.461

M3 - Article

C2 - 16756468

AN - SCOPUS:33745190962

VL - 16

SP - 461

EP - 469

JO - Thyroid

JF - Thyroid

SN - 1050-7256

IS - 5

ER -